|
Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor Clinical research trials and Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor. Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor clinical trial. Subjects frequently obtain the most expert healthcare possible for their Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor  Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor
Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor
For Condition: Pregnancy
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) ,
Synopsis: This proposal is a pilot study to describe the variations of blood sugar in pregnant women with various degrees of glucose intolerance, and how they relate to standardized meals. Blood sugar control during pregnancy is important to prevent complications for the newborn. The variation and timing of the blood sugar measurements in gestational diabetics and how this relates to the baby's outcome is controversial. We will use an FDA approved device called Minimed Glucose Continuous Monitor, which is used in clinical practice for certain diabetics. It is very small, similar to a beeper, and is connected to the patient through a small plastic catheter subcutaneously. This measures blood sugar every five minutes for a total of 288 readings a day with minimum discomfort. The hypothesis of this study is that use of the Minimed glucose monitor will provide information about variations of blood sugar in gestational diabetics that is missed by capillary glucose monitors. Our conclusions will allow us to compare blood glucose trends among the groups. After the data is analyzed in this pilot study, we plan to design a bigger study involving more subjects to study the impact of the blood sugar variations in the outcome of the newborn, and to obtain generalizable results for the population in general.
Details: We will coordinate the study through the CRC. The women will have to come in only twice, to have the monitor placed and then taken off three days later. A blood sample will be collected at each visit. Meals and snacks will be provided for each day of the study, specially packaged, to supply an equivalent amount of calories for each subject. These will meet the nutritional requirements for both the mother and the fetus. Women will do separate fingerstick blood sugar measurements using a capillary glucometer four times a day, to ensure the accuracy of the sensor's readings.
Eligibility:
Study Type: Observational, Cross-Sectional, Defined Population, Prospective Study
Minimum Age/Maximum Age: 18 Years/45 Years
Genders: Female
Protocol Entry Criteria: 1. Inclusion Criteria -Pregnant women, between 28 and 36 weeks of gestation. Gestational age will be determined by a combination of the date of the last menstrual period and ultrasound, done during the first or second trimester of pregnancy. -Previous glucose challenge test and if abnormal, an oral glucose tolerance test. -Body mass index (BMI) between 25 and 30 Kg/m2. -Gestational diabetes in a previous pregnancy, if glucose between pregnancies was normal.
Total Enrollment:
Location and Contact Information:
University of Texas Medical School
Houston, Texas, 40202
United States
Additional Information:
Study ID Numbers: NCRR-M01RR02558-0158;
Study Start Date:
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00011622
Other Pregnancy Studies:
1. Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS.
2. Emergency Contraception (ECP): Reducing Unintended Pregnancies
3. Problems Associated with the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women
4. Prenatal Screening For Smith-Lemli-Opitz Syndrome
5. Fortovase (Saquinavir) Given with Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
Related Studies:
Other Pregnancy Clinical Trials
Other Texas Clinical Trials
Other Houston Clinical Trials
Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor
|
|
|
|
|
|
|
|
